Impact Ethics

Disclaimer
Submit A Post
About
The Body Economy

Making a Difference in Bioethics

Tag Archives: Deborah Gleeson

Monopolies on New Medicines & Trade with the U.S.

November 14, 2018 · by impact ethics · in Pharmaceuticals, Public Health, Science and Technology

Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.

Learn about The Body Economy

Read Impact Ethics posts on The Body Economy

Watch: The Body Economy: Human Eggs in the Marketplace

Watch: The Body Economy: Surrogacy in the Marketplace

Watch: The Body Economy: Blood products in the Marketplace

Follow us on Twitter

Subscribe by email

Topics

Subscribe by RSS Feed

Bioethics Forum

Diving Deeper into Amazon Alexa’s HIPAA Compliance

Biopolitical Times

A Reading and Discussion with George Estreich

Fear & Loathing in Bioethics

"The Sackler Distinguished Lecture series, which has brought social-justice advocates to speak on the campus, seems to trigger particular revulsion among some faculty members."

Healthy Debate

PrEP could potentially eradicate HIV. But in Ontario, only about a 10th of the people it could help are taking it.

Practical Ethics

An Ambitious Vision for Bioethics – Some Reflections on Professor Jing-Bao Nie’s St Cross Seminar

Archives

Blog at WordPress.com.